Category: Biolase Technology Inc.
Boston Scientific names former Covidien CFO Charles Dockendorff and Hologic CEO Stephen MacMillan to its board of directors.
Biolase Technology Inc.
, Boston Scientific
, Breg Inc.
, Google Inc.
, Hologic Inc.
, Penumbra Inc.
JenaValve names medtech veteran Jan Keltjens to be its interim chairman & CEO, just 7 months after putting former AtriCure chief David Drachman in the corner office.
JenaValve tapped a medtech veteran with a string of successful exits behind him as interim chairman & CEO, replacing another medical device vet, David Drachman, after just 7 months.
Here's a look at some of the top legal news stories for medical device companies this week: Vascular Dynamics raises $10m; Spiracur raises $16m from GE Capital; Biolase lands $35m private placement; Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser
Dental laser maker Biolase lands a $35 million private placement with a group of investors that includes its chairman, chief executive officer and top stockholders.
Dental laser maker Biolase (NSDQ:BIOL) said in landed a $35 million private placement with a group of investors that includes its chairman, CEO and top stockholders.
Bluegrass Vascular Technologies taps former ArthroCare R&D chief Gabriele Niederauer to be its new president & CEO.
Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.
, Biolase Technology Inc.
, Bluegrass Vascular Technologies
, Bovie Medical Corp.
, Copan Group
, European Society of Cardiology
, Evaluate Ltd.
, LED Medical Diagnostics Inc.
, Medina Medical
, Royal Philips
, Smith & Nephew
, TYRX Inc.
GI Dynamics names ex-ATS Medical chief Michael Dale to replace Stuart Randle as CEO.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal; Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; Medtronic founder Bakken backs Covidien buy; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Allergan CFO Edwards steps down amid hostile Valeant takeover bid
, Biolase Technology Inc.
, Insulet Corp.
, Monarch Medical
, Pershing Square Capital Management
, Trinity Medical
, Valeant Pharmaceuticals
, Volpara Solutions
, Allergan Inc.